Cervical cancer test kit HPV 18/2

for sexually transmitted diseasesfor genotypingfor genes

Triage of patients with a typical squamous cells (ASCUS) who have no clear diagnostic significance; Predict the risk of cervical lesions worsening or postoperative recurrence; Guide the research and use of HPV vaccine; Early detection and treatment of cervical precancerous lesions can improve the prognosis and prolong the survival period of cervical cancer patients. Intended Use This kit is a qualitative in vitro test for the detection of human papillomavirus (HPV) in cervical exfoliated epithelial cells specimens. The test not only applies to detect 18 high-risk (HR) HPV types , including type 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 82, but also can identify the specific types of HPV16 and HPV18 simultaneously. General Specification Methodology: Real-Time PCR, PCR-Fluorescence Probing Sample Type: Exfoliate Cervical Cell / LBC Specimen Precision: CV <5% LoD: 5.0 * 104 copies/ml Packing Specifications 24 tests/kit (non-single test/tube) - 48 tests/kit (non-single test/tube) - 96 tests/lit (non-single test/tube) - 192 tests/lit (non-single test/tube) (Specifications can be customized according to actual needs.)